Two Sigma Investments’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$944K Sell
273,482
-36,383
-12% -$114K ﹤0.01% 3304
2025
Q4
$750K Buy
+309,865
New +$711K ﹤0.01% 3099
2025
Q2
Sell
-43,158
Closed -$76.8K 3657
2025
Q1
$76.8K Sell
43,158
-25,397
-37% -$66.3K ﹤0.01% 2993
2024
Q4
$216K Buy
68,555
+51,638
+305% +$117K ﹤0.01% 2852
2024
Q3
$34.8K Buy
+16,917
New +$27.3K ﹤0.01% 2987
2020
Q4
Sell
-2,633
Closed -$59K 3853
2020
Q3
$59K Buy
+2,633
New +$55.4K ﹤0.01% 2971
2020
Q2
Sell
-1,142
Closed -$9K 3627
2020
Q1
$9K Sell
1,142
-1,993
-64% -$18.4K ﹤0.01% 2991
2019
Q4
$29K Sell
3,135
-600
-16% -$5K ﹤0.01% 3586
2019
Q3
$38K Sell
3,735
-747
-17% -$8.28K ﹤0.01% 3362
2019
Q2
$61K Buy
+4,482
New +$68K ﹤0.01% 3236

Other funds holding WHWK

Two Sigma Investments's WHWK Position: Q1 2026 in Review

Two Sigma Investments reduced its Whitehawk Therapeutics (WHWK) stake by 12% in Q1 2026, selling an estimated $114K and leaving 273,482 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #3304.

Two Sigma Investments first reported a position in WHWK in Q2 2019 and has held it in 10 quarters since. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Two Sigma Investments held 273,482 shares of Whitehawk Therapeutics worth $944K as of Q1 2026.
  • Two Sigma Investments sold 36,383 Whitehawk Therapeutics shares in Q1 2026, an estimated $114K.
  • Whitehawk Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3304 holding.
  • Two Sigma Investments first reported a position in Whitehawk Therapeutics in Q2 2019 and has held it in 10 quarters since.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.